MediCarbone is Revolutionizing the IM Market
MediCarbone focuses on the development of an implantable carbon sleeve; custom-designed photocurable polymer formulation; and AI component that that come together to create a revolutionary solution. MediCarbone’s innovative, cost-effective approach has the power to benefit patients across the globe—fixing orthopedic injuries in civilian, military, degenerative bone disease and veterinary applications.
Our Team
Our team and advisory board contain multiple Ph.Ds, orthopedic bioengineering experts, chemists, orthopedic surgeons and proven medical entrepreneurs.
Be on The Front Lines of a Fracture Treatment Revolution.
MediCarbone uses FDA-cleared polymer components, and the device is moving rapidly toward clinical trials. North American Science Associates (NAMSA)—the world’s only 100% medical device-focused, full continuum Contract Research Organization (CRO)—will provide guidance on the regulatory pathway, evidence requirements, and pre-clinical and clinical testing plans to help MediCarbone towards FDA regulatory submissions. Learn how you can get involved now—and take advantage of a IM market that is expected to reach $1.2B by 2030.